Delivery Order SPE2DB20D1100-SPE2DB24FC5N0

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Junel FE 1 mg-20 mcg tablet in 28-count packages. The $1,803.63 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,285.66 firm fixed price delivery order contract is for the supply of the contraceptive drug Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of August 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Junel FE 1 mg-20 mcg tablets. The $6,790.84 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,313.85, is a delivery order for the pharmaceutical product "JUNEL FE 1.5 MG-30 MCG TABLET 28S". The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.63 firm fixed-price delivery order is for the supply of JUNEL FE 1 MG-20 MCG tablets in packages of 28. The contract has an ultimate completion date of June 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,148.34 fixed-price delivery order is for the pharmaceutical product "JUNEL FE 1.5 MG-30 MCG TABLET 28S", with a period of performance through November 2023. Amerisourcebergen is a large pharmaceutical distributor and healthcare solutions provider that maintains significant Indefinite Delivery Contracts (IDCs) with the DLA, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,976.56, is a Firm Fixed Price Delivery Order for the supply of Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of March 31, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.35 Firm Fixed Price delivery order is for the supply of JUNEL FE 1.5 MG-30 MCG Tablets 28s, a medication used in the treatment of various medical conditions. The contract has an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,870.82 firm fixed-price delivery order is for the supply of 4564829438 - JUNEL FE 1 MG-20 MCG TABLET 28S, with a completion date of June 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,010.47 firm-fixed-price delivery order covers the supply of the generic pharmaceutical product Junel FE 1 mg-20 mcg tablets. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC5N0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of JUNEL FE 1 MG-20 MCG TABLET 28S. The $7,558.75 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 3, 2024.

Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.

Generated 10/1/24, 12:05 PM